Literature DB >> 22806413

Prediction of coronary artery disease in patients undergoing operations for rheumatic aortic valve disease.

Tao Yan1, Guan-xin Zhang, Bai-ling Li, Lin Han, Jia-jie Zang, Li Li, Zhi-yun Xu.   

Abstract

BACKGROUND: We sought to develop and validate a logistic model and a simple score system for prediction of significant coronary artery disease (CAD) in patients undergoing operations for rheumatic aortic valve disease. HYPOTHESIS: The simple score model we established based on the logistic model was efficient and practical.
METHODS: A total of 669 rheumatic patients (mean age 51 ± 9 years), who underwent routine coronary angiography (CAG) before aortic valve surgery between 1998 and 2010, were analyzed. A bootstrap-validated logistic regression model on the basis of clinical risk factors was developed to identify low-risk (≤5%) patients, from which an additive model was derived. Receiver operating characteristic (ROC) curves were used to compare discrimination, and precision was quantified by the Hosmer-Lemeshow statistic. Significant coronary atherosclerosis was defined as 50% or more luminal narrowing in 1 or more major epicardial vessels determined by means of coronary angiography.
RESULTS: Eighty-eight (13.2%) patients had significant coronary atherosclerosis. Independent predictors of CAD include age, angina, diabetes mellitus, and hypertension. A total of 325 patients were designated as low risk according to the bootstrap logistic regression and additive models. Of these patients, only 4 (1.2%) had single-vessel disease, and none had high-risk CAD (ie, left main trunk, proximal left anterior descending, or multivessel disease). The bootstrap logistic regression and additive models show good discrimination, with an area under the ROC curve of 0.948 and 0.942, respectively.
CONCLUSIONS: Our logistic regression model can reliably estimate the prevalence of significant CAD in rheumatic patients undergoing aortic valve operation, while the additive simple score system could reliably identify the low-risk patients in whom routine preoperative angiography might be safely avoided.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22806413      PMCID: PMC6652433          DOI: 10.1002/clc.22033

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  28 in total

1.  An Introduction to Model Selection.

Authors: 
Journal:  J Math Psychol       Date:  2000-03       Impact factor: 2.223

Review 2.  Aortic valve replacement: an update at the turn of the millennium.

Authors:  E Braunwald
Journal:  Eur Heart J       Date:  2000-07       Impact factor: 29.983

3.  Right ventricular hypertension as a cause of precordial pain.

Authors:  R S ROSS
Journal:  Am Heart J       Date:  1961-01       Impact factor: 4.749

4.  Prevalence of coronary artery disease in patients with rheumatic heart disease in the current era.

Authors:  V Jacob Jose; Satya N Gupta; George Joseph; Sunil Thomas Chandy; Oommen K George; Purendra Kumar Pati; Bobby John; Paul George
Journal:  Indian Heart J       Date:  2004 Mar-Apr

Review 5.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Chatterjee Kanu; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-08-01       Impact factor: 29.690

6.  Bootstrap resampling: a powerful method of assessing confidence intervals for doses from experimental data.

Authors:  G Iwi; R K Millard; A M Palmer; A W Preece; M Saunders
Journal:  Phys Med Biol       Date:  1999-04       Impact factor: 3.609

7.  Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients with aortic valve stenosis.

Authors:  Martine Gilard; Jean-Christophe Cornily; Pierre-Yves Pennec; Cedric Joret; Grégoire Le Gal; Jacques Mansourati; Jean-Jacques Blanc; Jacques Boschat
Journal:  J Am Coll Cardiol       Date:  2006-04-24       Impact factor: 24.094

8.  Predictive value of noninvasive coronary angiography with multidetector computed tomography to detect significant coronary stenosis before valve surgery.

Authors:  Patricia Reant; Sebastien Brunot; Stephane Lafitte; Karim Serri; Lionel Leroux; Olivier Corneloup; Xavier Iriart; Pierre Coste; Pierre Dos Santos; Raymond Roudaut; François Laurent
Journal:  Am J Cardiol       Date:  2006-03-29       Impact factor: 2.778

Review 9.  [Prevalence of coronary disease in patients with aortic stenosis].

Authors:  J C García Rubira; D Romero Chacón; D Naranjo; F Marcos; J Calderón; J M Cruz; J Cubero
Journal:  Rev Esp Cardiol       Date:  1992 Aug-Sep       Impact factor: 4.753

10.  A simple model to predict coronary disease in patients undergoing operation for mitral regurgitation.

Authors:  Eric Lim; Ziad A Ali; Clifford W Barlow; Christopher H Jackson; Amir-Reza Hosseinpour; James C Halstead; John B Barlow; Francis C Wells
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

View more
  1 in total

1.  Prevalence and Prediction of Obstructive Coronary Artery Disease in Patients Undergoing Primary Heart Valve Surgery.

Authors:  José Guilherme Cazelli; Gabriel Cordeiro Camargo; Dany David Kruczan; Clara Weksler; Alexandre Rouge Felipe; Ilan Gottlieb
Journal:  Arq Bras Cardiol       Date:  2017-09-28       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.